MedTrace Logo

The Effect of Aromatherapy Application on Pain, Stress and Behaviors of the Newborn

NCT05770999 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2024-12-13

No results posted yet for this study

Summary

This study was planned as a randomized controlled double-blind experimental study to examine the effect of aromatherapy on newborn pain, stress and behaviors. The main questions it aims to answer are:

* Lavender oil massage applied to newborns has an effect on pain, stress and behavior of newborns.
* Lavender oil bath applied to newborns has an effect on pain, stress and behavior of newborns.
* There is a difference between lavender oil massage and lavender oil bath applications applied to newborns in reducing the pain and stress level of the newborn and regulating their behavior.

Randomization method will be used in the determination of the study groups (Lavender massage, lavender bath and control group), and the study group to which the newborns will be included will be determined in the computer environment. Gender, gestational age, postnatal age and body weight will be considered as matching criteria for newborns included in lavender massage, lavender bath and control groups. For ALPS-Neo and ABSS evaluations, 10 minutes (20 minutes in total) of newborns will be recorded with a video camera before and after the study.

Conditions

  • Newborn, Infant, Disease

Interventions

OTHER

Lavender application

Lavender application

Sponsors & Collaborators

  • TC Erciyes University

    lead OTHER

Principal Investigators

  • Öznur BAŞDAŞ, PhD · TC Erciyes University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
5 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-21
Primary Completion
2022-09-20
Completion
2022-10-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05770999 on ClinicalTrials.gov